U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07422259) titled 'Tolerability and Efficacy Study of Reinnerva/Lubristil+G vs Vismed' on Feb. 03.
Brief Summary: The clinical investigation #1122 is a Post Market Clinical Follow Up Study on the EC marked medical device Reinnerva/Lubristil +G, sterile eye drops, compared to Vismed medical device, sterile eye drops, to demonstrate the clinical performance and tolerability of Reinnerva/Lubristil +G to stabilize the lacrimal film and improve the ocular surface condition in the cases of quali-quantitative alterations of the tear film .
Study Start Date: June 09, 2025
Study Type: INTERVENTIONAL
Condition:
Keratoconjunctivitis Sicca
Intervention:
DEV...